Chimerix Inc (CMRX)
0.9944
+0.02
(+2.54%)
USD |
NASDAQ |
May 17, 16:00
0.9944
0.00 (0.00%)
After-Hours: 20:00
Chimerix Total Return Level: 0.9875 for May 17, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 17, 2024 | 0.9875 |
May 16, 2024 | 0.9698 |
May 15, 2024 | 0.9775 |
May 14, 2024 | 1.00 |
May 13, 2024 | 1.05 |
May 10, 2024 | 0.9705 |
May 09, 2024 | 1.01 |
May 08, 2024 | 0.9706 |
May 07, 2024 | 0.99 |
May 06, 2024 | 1.00 |
May 03, 2024 | 0.9529 |
May 02, 2024 | 0.9502 |
May 01, 2024 | 0.95 |
April 30, 2024 | 0.94 |
April 29, 2024 | 0.9346 |
April 26, 2024 | 0.8999 |
April 25, 2024 | 0.891 |
April 24, 2024 | 0.906 |
April 23, 2024 | 0.9253 |
April 22, 2024 | 0.9139 |
April 19, 2024 | 0.8844 |
April 18, 2024 | 0.9323 |
April 17, 2024 | 0.904 |
April 16, 2024 | 0.9201 |
April 15, 2024 | 0.9146 |
Date | Value |
---|---|
April 12, 2024 | 0.9607 |
April 11, 2024 | 0.99 |
April 10, 2024 | 0.999 |
April 09, 2024 | 0.99 |
April 08, 2024 | 1.00 |
April 05, 2024 | 1.03 |
April 04, 2024 | 1.04 |
April 03, 2024 | 1.04 |
April 02, 2024 | 1.01 |
April 01, 2024 | 1.05 |
March 28, 2024 | 1.06 |
March 27, 2024 | 1.01 |
March 26, 2024 | 0.99 |
March 25, 2024 | 0.9845 |
March 22, 2024 | 0.9998 |
March 21, 2024 | 0.956 |
March 20, 2024 | 0.99 |
March 19, 2024 | 0.96 |
March 18, 2024 | 1.10 |
March 15, 2024 | 1.15 |
March 14, 2024 | 1.14 |
March 13, 2024 | 1.17 |
March 12, 2024 | 1.18 |
March 11, 2024 | 1.24 |
March 08, 2024 | 1.26 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.8844
Minimum
Apr 19 2024
11.25
Maximum
Feb 17 2021
3.354
Average
2.30
Median
Sep 16 2019
Total Return Level Benchmarks
UFP Technologies Inc | 259.75 |
Dentsply Sirona Inc | 34.89 |
Arbutus Biopharma Corp | 2.98 |
Pacira BioSciences Inc | 30.82 |
Karyopharm Therapeutics Inc | 1.15 |